Humatica AG was retained to advise Capvis on its majority investment in Austrian firm AMANN GIRRBACH AG, a pioneer in dental CAD/CAM technology. The firm is a leading innovator in the field and a full-service provider for digital dental prosthetics.
Humatica provided organisational due diligence services for this transaction.
To view press release: Humatica advises Capvis on their recent investment in AMANN GIRRBACH
Firsthand strategies from portfolio company CEO’s who outperformed in uncertain times Portfolio company leaders are facing bigger challenges than ever before. Unprecedented macro-headwinds from increased…
Read moreZurich, 10 July 2025 – Humatica posted further growth in the first half of 2025, topping record same-period growth last year. Consulting fee revenues increased…
Read moreAccelerating behavioral change to improve business performance GloCoach, the global leader in AI-enabled leadership development and coaching, and Humatica, the leading advisor in organizational effectiveness…
Read more